64 active trials 46 recruiting 13 disease areas 4 changes in 30 days
3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.
Recruitment opened
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not specified NCT07619547 Registry history of NCT07619547 on ClinicalTrials.gov (opens the registry)
Changed
Enrollment closed, study ongoing
Also in this update: Final enrollment: 12 participants (planned 50)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2 NCT06092333 Registry history of NCT06092333 on ClinicalTrials.gov (opens the registry)
Updated
Start date changed from estimate of Oct 12, 2026 to Oct 5, 2026
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not specified NCT07191561 Registry history of NCT07191561 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 1 | 2 | |
| Phase 1/2 | 1 | |
| Phase 2 | 20 | |
| Phase 2/3 | 1 | |
| Phase 3 | 1 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT03520660 | People With CHC Who Achieved a Sustained Virological Response Following Therapy With… | Diabetes Mellitus | Active, Not Recruiting | 2026-10-02 |
| Phase 3 | ||||
| NCT02262832 | Compassionate Use of Metreleptin in Previously Treated People With Generalized… | Lipodystrophy | Active, Not Recruiting | 2026-09-22 |
| Phase 2/3 | ||||
| NCT07444723 | Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of… | Primary Hyperparathyroidism | Recruiting | 2026-06-02 |
| Phase 2 | ||||
| NCT04927416 | The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer | Metastic Thyroid Cancer | Recruiting | 2026-10-05 |
| NCT02019706 | Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in… | ACTH | Recruiting | 2026-10-02 |
| NCT05832229 | Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United… | Cirrhosis | Recruiting | 2026-09-28 |
| NCT00977977 | Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy | Nephrotic Syndrome | Recruiting | 2026-09-22 |
| NCT03841617 | The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer | Thyroid Cancer | Recruiting | 2026-09-09 |
| NCT07216391 | Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG | Type 1 Diabetes Mellitus | Recruiting | 2026-09-09 |
| NCT07142252 | Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus | Type 1 Diabetes Mellitus | Recruiting | 2026-09-08 |
| NCT06635629 | Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome | Cushing Syndrome | Recruiting | 2026-08-31 |
| NCT05470504 | Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance | Insulin Receptor Mutation | Recruiting | 2026-08-18 |
| NCT03884075 | Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect… | Non-Alcoholic Steatohepatitis | Recruiting | 2026-08-10 |
| NCT05713799 | Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With… | Insulin Resistance | Not Yet Recruiting | 2026-10-09 |
| NCT07313787 | Effects of Meal Macronutrients on Postprandial Lipids | Nephrotic Syndrome | Not Yet Recruiting | 2026-10-09 |
| NCT00739362 | Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment | Electric Stimulation Therapy | Active, Not Recruiting | 2026-10-08 |
| NCT02262806 | Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy | Diabetes | Active, Not Recruiting | 2026-10-08 |
| NCT06092333 | VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B | Chronic Hepatitis B | Active, Not Recruiting | 2026-10-05 |
| NCT05743244 | Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1… | Diabetes Mellitus, Type 1 | Active, Not Recruiting | 2026-09-02 |
| NCT03929601 | Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes | Type 1 Diabetes Mellitus | Active, Not Recruiting | 2026-09-01 |
| NCT04862221 | TReatment for ImmUne Mediated PathopHysiology | Acute Liver Failure | Active, Not Recruiting | 2026-08-12 |
| NCT07683026 | Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo | Type 1 Diabetes (T1D) | Not Yet Recruiting | 2026-07-06 |
| NCT00085982 | Effect of Metreleptin Therapy in the Treatment of Severe Insulin Resistance | Severe Insulin Resistance | Active, Not Recruiting | 2025-01-30 |
| Phase 1/2 | ||||
| NCT06991738 | 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive… | Thyroid Cancer | Not Yet Recruiting | 2026-10-09 |
| Phase 1 | ||||
| NCT04799301 | Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake | Diet Therapy | Recruiting | 2026-09-14 |
Diabetes (18) · Obesity (12) · Thyroid Cancer (5) · Type 1 Diabetes (5) · Heart Disease (4) · Chronic Kidney Disease (2) · Hypertension (2) · NASH / MASH (2) · Crohn's Disease (1) · Cystic Fibrosis (1)